Successful Outcomes of Brentuximab Vedotin Therapy in Recurrent/Refractory Cutaneous T-Cell Lymphomas: Two Case Reports
Immunopathology, Allergology, Infectology
doi 10.14427/jipai.2018.3.78
Full Text
Open PDFAbstract
Available in full text
Date
July 1, 2018
Authors
Publisher
All-Russian National Academy of Mycology